Table 4.
Within-group Comparison of FRAX (Rt HFP), Z score (Lt FN), FRAX(Lt HFP), FRAX (Lt HPMO), and Z score(LS).
| Variable | Groups | N | Pretreatment Mean ± SD | Posttreatment Mean ± SD | Median | ES Cohen’s d (95% CI) | Z value | p value | |
|---|---|---|---|---|---|---|---|---|---|
| Pretreatment | Posttreatment | ||||||||
| FRAX (Rt HFP.) | EXP | 22 | 0.50 ± 0.31 | 0.37 ± 0.25 | 0.35 | 0.20 | 0.85(0.35,1.33) | − 3.30 | < 0.001 |
| CON | 21 | 0.51 ± 0.26 | 0.49 ± 0.26 | 0.50 | 0.40 | 0.47(0.02,0.92) | − 2.0 | 0.05 | |
| Z Score (Lt FN) | EXP | 22 | − 0.27 ± 0.72 | − 0.05 ± 0.61 | 0.20 | 0.10 | 0.18 (− 0.24, − 0.6) | − 0.73 | 0.47 |
| CON | 21 | − 0.18 ± 0.88 | − 0.17 ± 0.88 | 0.10 | 0.10 | − 0.15 (0.58,0.28) | − 0.71 | 0.48 | |
| FRAX (Lt HFP) | EXP | 22 | 0.58 ± 0.32 | 0.39 ± 0.23 | 0.40 | 0.30 | 1.40 (0.80,1.99) | − 4.00 | < 0.001 |
| CON | 21 | 0.51 ± 0.25 | 0.51 ± 0.24 | 0.50 | 0.50 | 0.19 (− 0.24,0.63) | − 0.45 | 0.66 | |
| FRAX (Lt HPMO) | EXPMO | 22 | 7.15 ± 1.62 | 6.52 ± 1.51 | 6.95 | 6.55 | 1.01 (0.49,1.52) | − 4.12 | < 0.001 |
| CON | 21 | 6.38 ± 2.13 | 6.36 ± 2.10 | 7.00 | 7.00 | 0.25 (− 1.89,0.68) | − 1.13 | 0.26 | |
| Z Score (LS) | EXP | 22 | 0.46 ± 1.18 | 0.45 ± 1.10 | 0.55 | 0.3 | 0.08 (− 0.33,0.49) | − 0.38 | 0.71 |
| CON | 21 | 0.77 ± 2.10 | 0.76 ± 2.10 | 0.90 | 0.80 | 0.178 (0.26,0.61) | − 0.82 | 0.41 | |
Results are represented as the mean and standard deviation (±); FRAX fracture risk assessment tool, HFP hip fracture prediction, HPMO hip prediction of major osteoporosis, ES effect size.